nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxandrolone—Peliosis hepatis—Tamoxifen—pancreatic cancer	0.0955	0.143	CcSEcCtD
Oxandrolone—Oligospermia—Gemcitabine—pancreatic cancer	0.0393	0.0588	CcSEcCtD
Oxandrolone—Azoospermia—Gemcitabine—pancreatic cancer	0.0306	0.0458	CcSEcCtD
Oxandrolone—Priapism—Tamoxifen—pancreatic cancer	0.0248	0.0371	CcSEcCtD
Oxandrolone—Menstruation irregular—Tamoxifen—pancreatic cancer	0.0216	0.0324	CcSEcCtD
Oxandrolone—Hepatic necrosis—Tamoxifen—pancreatic cancer	0.0206	0.0309	CcSEcCtD
Oxandrolone—Hirsutism—Erlotinib—pancreatic cancer	0.0204	0.0305	CcSEcCtD
Oxandrolone—AR—FOXA1 transcription factor network—TFF1—pancreatic cancer	0.019	0.0573	CbGpPWpGaD
Oxandrolone—Oligospermia—Epirubicin—pancreatic cancer	0.0188	0.0282	CcSEcCtD
Oxandrolone—AR—Nuclear Receptors—NR5A2—pancreatic cancer	0.0179	0.054	CbGpPWpGaD
Oxandrolone—Oligospermia—Doxorubicin—pancreatic cancer	0.0174	0.026	CcSEcCtD
Oxandrolone—Azoospermia—Epirubicin—pancreatic cancer	0.0146	0.0219	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—RBBP8—pancreatic cancer	0.0143	0.0432	CbGpPWpGaD
Oxandrolone—AR—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.0142	0.0427	CbGpPWpGaD
Oxandrolone—Acne—Erlotinib—pancreatic cancer	0.0141	0.0211	CcSEcCtD
Oxandrolone—Azoospermia—Doxorubicin—pancreatic cancer	0.0135	0.0203	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BACH1—pancreatic cancer	0.013	0.039	CbGpPWpGaD
Oxandrolone—Creatinine increased—Tamoxifen—pancreatic cancer	0.0126	0.0188	CcSEcCtD
Oxandrolone—Acne—Sunitinib—pancreatic cancer	0.0122	0.0183	CcSEcCtD
Oxandrolone—Fluid retention—Tamoxifen—pancreatic cancer	0.0114	0.017	CcSEcCtD
Oxandrolone—Neoplasm—Tamoxifen—pancreatic cancer	0.0108	0.0162	CcSEcCtD
Oxandrolone—Creatinine increased—Sunitinib—pancreatic cancer	0.0108	0.0161	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—HEY2—pancreatic cancer	0.0107	0.0323	CbGpPWpGaD
Oxandrolone—Menstruation irregular—Docetaxel—pancreatic cancer	0.0106	0.0158	CcSEcCtD
Oxandrolone—Necrosis—Fluorouracil—pancreatic cancer	0.0103	0.0154	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—HEY1—pancreatic cancer	0.00994	0.0299	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—GDI1—pancreatic cancer	0.00982	0.0296	CbGpPWpGaD
Oxandrolone—Neoplasm—Sunitinib—pancreatic cancer	0.00928	0.0139	CcSEcCtD
Oxandrolone—AR—FOXA1 transcription factor network—SHH—pancreatic cancer	0.00874	0.0263	CbGpPWpGaD
Oxandrolone—Creatinine increased—Gemcitabine—pancreatic cancer	0.00865	0.0129	CcSEcCtD
Oxandrolone—Blood creatinine increased—Tamoxifen—pancreatic cancer	0.00815	0.0122	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—DAXX—pancreatic cancer	0.00787	0.0237	CbGpPWpGaD
Oxandrolone—Fluid retention—Gemcitabine—pancreatic cancer	0.00782	0.0117	CcSEcCtD
Oxandrolone—Neoplasm—Irinotecan—pancreatic cancer	0.00764	0.0114	CcSEcCtD
Oxandrolone—Necrosis—Docetaxel—pancreatic cancer	0.00744	0.0111	CcSEcCtD
Oxandrolone—Blood creatinine increased—Sunitinib—pancreatic cancer	0.00698	0.0104	CcSEcCtD
Oxandrolone—Erectile dysfunction—Tamoxifen—pancreatic cancer	0.00692	0.0104	CcSEcCtD
Oxandrolone—AR—FOXA1 transcription factor network—GCG—pancreatic cancer	0.00675	0.0203	CbGpPWpGaD
Oxandrolone—Haemoglobin—Tamoxifen—pancreatic cancer	0.00605	0.00905	CcSEcCtD
Oxandrolone—Haemorrhage—Tamoxifen—pancreatic cancer	0.00602	0.00901	CcSEcCtD
Oxandrolone—Haemoglobin—Erlotinib—pancreatic cancer	0.00598	0.00896	CcSEcCtD
Oxandrolone—Haemorrhage—Erlotinib—pancreatic cancer	0.00595	0.00891	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.00588	0.0177	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Irinotecan—pancreatic cancer	0.00575	0.0086	CcSEcCtD
Oxandrolone—Irritability—Fluorouracil—pancreatic cancer	0.00561	0.0084	CcSEcCtD
Oxandrolone—Blood creatinine increased—Gemcitabine—pancreatic cancer	0.0056	0.00838	CcSEcCtD
Oxandrolone—Fluid retention—Docetaxel—pancreatic cancer	0.00555	0.0083	CcSEcCtD
Oxandrolone—Neoplasm—Docetaxel—pancreatic cancer	0.00528	0.00791	CcSEcCtD
Oxandrolone—Haemoglobin—Sunitinib—pancreatic cancer	0.00518	0.00775	CcSEcCtD
Oxandrolone—Haemorrhage—Sunitinib—pancreatic cancer	0.00515	0.00771	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—HES1—pancreatic cancer	0.00515	0.0155	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—SSTR1—pancreatic cancer	0.00502	0.0151	CbGpPWpGaD
Oxandrolone—Necrosis—Epirubicin—pancreatic cancer	0.00502	0.00752	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.00484	0.0146	CbGpPWpGaD
Oxandrolone—Necrosis—Doxorubicin—pancreatic cancer	0.00465	0.00695	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Epirubicin—pancreatic cancer	0.00448	0.00671	CcSEcCtD
Oxandrolone—AR—Nuclear Receptors—PPARG—pancreatic cancer	0.00435	0.0131	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—HIF1A—pancreatic cancer	0.00432	0.013	CbGpPWpGaD
Oxandrolone—Oedema—Tamoxifen—pancreatic cancer	0.00427	0.0064	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.00427	0.0129	CbGpPWpGaD
Oxandrolone—Haemoglobin—Irinotecan—pancreatic cancer	0.00427	0.00639	CcSEcCtD
Oxandrolone—Haemorrhage—Irinotecan—pancreatic cancer	0.00424	0.00635	CcSEcCtD
Oxandrolone—Oedema—Erlotinib—pancreatic cancer	0.00423	0.00633	CcSEcCtD
Oxandrolone—Haemoglobin—Gemcitabine—pancreatic cancer	0.00415	0.00622	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Doxorubicin—pancreatic cancer	0.00415	0.00621	CcSEcCtD
Oxandrolone—Creatinine increased—Epirubicin—pancreatic cancer	0.00414	0.0062	CcSEcCtD
Oxandrolone—Haemorrhage—Gemcitabine—pancreatic cancer	0.00413	0.00619	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—KDR—pancreatic cancer	0.00413	0.0124	CbGpPWpGaD
Oxandrolone—Haemoglobin—Fluorouracil—pancreatic cancer	0.00409	0.00612	CcSEcCtD
Oxandrolone—Haemorrhage—Fluorouracil—pancreatic cancer	0.00406	0.00609	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—NOTCH1—pancreatic cancer	0.00389	0.0117	CbGpPWpGaD
Oxandrolone—Insomnia—Tamoxifen—pancreatic cancer	0.00387	0.00579	CcSEcCtD
Oxandrolone—Creatinine increased—Doxorubicin—pancreatic cancer	0.00383	0.00573	CcSEcCtD
Oxandrolone—Insomnia—Erlotinib—pancreatic cancer	0.00382	0.00573	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.00381	0.0115	CbGpPWpGaD
Oxandrolone—Fluid retention—Epirubicin—pancreatic cancer	0.00374	0.0056	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—AHR—pancreatic cancer	0.00373	0.0112	CbGpPWpGaD
Oxandrolone—Oedema—Sunitinib—pancreatic cancer	0.00366	0.00548	CcSEcCtD
Oxandrolone—Neoplasm—Epirubicin—pancreatic cancer	0.00356	0.00533	CcSEcCtD
Oxandrolone—AR—Notch-mediated HES/HEY network—RB1—pancreatic cancer	0.00351	0.0106	CbGpPWpGaD
Oxandrolone—Fluid retention—Doxorubicin—pancreatic cancer	0.00346	0.00518	CcSEcCtD
Oxandrolone—AR—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.00344	0.0104	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—SMAD4—pancreatic cancer	0.00341	0.0103	CbGpPWpGaD
Oxandrolone—Insomnia—Sunitinib—pancreatic cancer	0.00331	0.00496	CcSEcCtD
Oxandrolone—Neoplasm—Doxorubicin—pancreatic cancer	0.0033	0.00494	CcSEcCtD
Oxandrolone—AR—Nongenotropic Androgen signaling—SRC—pancreatic cancer	0.00326	0.00981	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—SMAD4—pancreatic cancer	0.00317	0.00953	CbGpPWpGaD
Oxandrolone—Oedema—Irinotecan—pancreatic cancer	0.00301	0.00451	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.00301	0.00906	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—pancreatic cancer	0.00295	0.00888	CbGpPWpGaD
Oxandrolone—Haemoglobin—Docetaxel—pancreatic cancer	0.00295	0.00441	CcSEcCtD
Oxandrolone—Oedema—Gemcitabine—pancreatic cancer	0.00294	0.0044	CcSEcCtD
Oxandrolone—Haemorrhage—Docetaxel—pancreatic cancer	0.00293	0.00439	CcSEcCtD
Oxandrolone—Oedema—Fluorouracil—pancreatic cancer	0.00289	0.00432	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—GADD45A—pancreatic cancer	0.00276	0.00832	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.00275	0.00829	CbGpPWpGaD
Oxandrolone—Insomnia—Irinotecan—pancreatic cancer	0.00273	0.00408	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.0027	0.00813	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Epirubicin—pancreatic cancer	0.00268	0.00401	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.00267	0.00803	CbGpPWpGaD
Oxandrolone—Insomnia—Gemcitabine—pancreatic cancer	0.00266	0.00398	CcSEcCtD
Oxandrolone—Insomnia—Fluorouracil—pancreatic cancer	0.00261	0.00391	CcSEcCtD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CDKN2A—pancreatic cancer	0.00251	0.00755	CbGpPWpGaD
Oxandrolone—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.00248	0.00371	CcSEcCtD
Oxandrolone—AR—Nongenotropic Androgen signaling—PIK3CA—pancreatic cancer	0.00248	0.00746	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.00245	0.00737	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—STK11—pancreatic cancer	0.00237	0.00713	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.00233	0.00702	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—HRAS—pancreatic cancer	0.00229	0.0069	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.00229	0.0069	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—pancreatic cancer	0.00229	0.00689	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—STAT3—pancreatic cancer	0.00225	0.00678	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—pancreatic cancer	0.0022	0.00663	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BRCA2—pancreatic cancer	0.00214	0.00645	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—SRC—pancreatic cancer	0.00212	0.00639	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CCND1—pancreatic cancer	0.00212	0.00638	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—RB1—pancreatic cancer	0.00211	0.00635	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CTNNB1—pancreatic cancer	0.0021	0.00631	CbGpPWpGaD
Oxandrolone—Oedema—Docetaxel—pancreatic cancer	0.00208	0.00312	CcSEcCtD
Oxandrolone—AR—Integrated Breast Cancer Pathway—SMAD4—pancreatic cancer	0.00207	0.00624	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—AKT1—pancreatic cancer	0.00202	0.00609	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—pancreatic cancer	0.00202	0.00607	CbGpPWpGaD
Oxandrolone—Haemoglobin—Epirubicin—pancreatic cancer	0.00199	0.00298	CcSEcCtD
Oxandrolone—Haemorrhage—Epirubicin—pancreatic cancer	0.00198	0.00296	CcSEcCtD
Oxandrolone—AR—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.00197	0.00594	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.00196	0.00591	CbGpPWpGaD
Oxandrolone—Insomnia—Docetaxel—pancreatic cancer	0.00189	0.00282	CcSEcCtD
Oxandrolone—Haemoglobin—Doxorubicin—pancreatic cancer	0.00184	0.00276	CcSEcCtD
Oxandrolone—Haemorrhage—Doxorubicin—pancreatic cancer	0.00183	0.00274	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—pancreatic cancer	0.00183	0.00551	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.00177	0.00534	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.00172	0.00517	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—pancreatic cancer	0.0017	0.00513	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TSC2—pancreatic cancer	0.00169	0.0051	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—pancreatic cancer	0.00169	0.00508	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.00169	0.00508	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—pancreatic cancer	0.00165	0.00498	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.00165	0.00498	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CCND1—pancreatic cancer	0.00157	0.00471	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CTNNB1—pancreatic cancer	0.00155	0.00467	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—PTEN—pancreatic cancer	0.00151	0.00455	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—CHD3—pancreatic cancer	0.00141	0.00423	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—MEN1—pancreatic cancer	0.00141	0.00423	CbGpPWpGaD
Oxandrolone—Oedema—Epirubicin—pancreatic cancer	0.00141	0.0021	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—SRC—pancreatic cancer	0.0014	0.00422	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	0.00138	0.00416	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	0.00138	0.00414	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—pancreatic cancer	0.00137	0.00412	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	0.00135	0.00408	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—STAT3—pancreatic cancer	0.00135	0.00407	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.00133	0.00401	CbGpPWpGaD
Oxandrolone—Oedema—Doxorubicin—pancreatic cancer	0.0013	0.00195	CcSEcCtD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.00128	0.00385	CbGpPWpGaD
Oxandrolone—Insomnia—Epirubicin—pancreatic cancer	0.00127	0.0019	CcSEcCtD
Oxandrolone—AR—Androgen receptor signaling pathway—EGFR—pancreatic cancer	0.00123	0.0037	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.00122	0.00369	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NR5A2—pancreatic cancer	0.00118	0.00355	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—AKT1—pancreatic cancer	0.00118	0.00355	CbGpPWpGaD
Oxandrolone—Insomnia—Doxorubicin—pancreatic cancer	0.00118	0.00176	CcSEcCtD
Oxandrolone—AR—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.00113	0.00341	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.00107	0.00323	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	0.00105	0.00317	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.00103	0.00309	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	0.00103	0.00309	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	0.00102	0.00306	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	0.00099	0.00298	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.000989	0.00298	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.00094	0.00283	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	0.000939	0.00283	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	0.000894	0.00269	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.000873	0.00263	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000871	0.00262	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—AKT1—pancreatic cancer	0.000871	0.00262	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000854	0.00257	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.00085	0.00256	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.000841	0.00253	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	0.000822	0.00248	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.00082	0.00247	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	0.000804	0.00242	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.000761	0.00229	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	0.00076	0.00229	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000746	0.00225	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.000741	0.00223	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.000682	0.00205	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.00068	0.00205	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—MEN1—pancreatic cancer	0.000677	0.00204	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	0.000675	0.00203	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.000667	0.00201	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NOTCH4—pancreatic cancer	0.000642	0.00193	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.000635	0.00191	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.00063	0.0019	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000629	0.00189	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—HSPA1B—pancreatic cancer	0.000612	0.00184	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000594	0.00179	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	0.000579	0.00174	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	0.00057	0.00172	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.00056	0.00169	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—EZH2—pancreatic cancer	0.000557	0.00168	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NOTCH3—pancreatic cancer	0.000546	0.00164	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—HSPA1A—pancreatic cancer	0.000517	0.00156	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.000473	0.00142	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—SMAD4—pancreatic cancer	0.000411	0.00124	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—MYC—pancreatic cancer	0.000339	0.00102	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—NOTCH1—pancreatic cancer	0.000303	0.000912	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—PPARG—pancreatic cancer	0.000286	0.000861	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—MYC—pancreatic cancer	0.000163	0.000491	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—AKT1—pancreatic cancer	0.000113	0.00034	CbGpPWpGaD
